Evaluating the Efficacy, Toxicity and Pharmacokinetic Profile of Oral Busulfan in Allogeneic Stem Cell Transplant Patients

BACKGROUND: Oral busulfan and intravenous cyclophosphamide (Bu/Cy) are common myeloablative preparations used in allogeneic hematopoietic stem cell transplantation (HSCT). Herein, we investigated the safety of (Bu/Cy) administration during HSCT. METHODS: Patients administered Bu/Cy for allogeneic HS...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvaris, Ross, Salman, Sam, O'Halloran, Sean, Joyce, David, Mathew, Navin, Cooney, Julian, Wright, Matthew, Cannell, Paul, Purtill, Duncan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870685/
https://www.ncbi.nlm.nih.gov/pubmed/36710948
http://dx.doi.org/10.31547/bct-2021-019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870685/
https://www.ncbi.nlm.nih.gov/pubmed/36710948
http://dx.doi.org/10.31547/bct-2021-019

Ejemplares similares